American Regent Resumes Shipment of Injectable Products

American Regent Resumes Shipment of Injectable Products       
American Regent announced today that it had resumed the shipment of its multisource injectable products on May 5, 2011.  Release of products is being prioritized and American Regent is working closely with the FDA Drug Shortage Staff to ensure that supplies of critically needed medications are available for patient care.

Please Note: Products have been shipped and are available from your local Wholesaler or Distributor.

In addition to Venofer® (iron sucrose injection, USP), the following products have been released and shipped:

Atropine Sulfate Injection, USP
 
Caffeine Citrate Injection, USP
 
Chromic Chloride Injection, USP
 
Concentrated Zinc Sulfate Injection, USP
 
Dehydrated Alcohol Injection, USP
 
Dopamine HCL Injection, USP
 
Droperidol Injection, USP
 
Glycopyrrolate Injection, USP
 
Hydroxyzine HCL Injection, USP
 
Iron Dextran Injection, USP (Dexferrum®)
 
L-Cysteine HCL Injection, USP
 
Multitrace® -4 (Trace Elements Injection 4, USP)
 
Multitrace® -4 Concentrate (Trace Elements Injection 4, USP - Concentrate)
 
Multitrace® -5 Concentrate (Trace Elements Injection 5, USP - Concentrate)
 
Neostigmine Methylsulfate Injection, USP  
 
Nitroglycerin Injection, USP
 
Papaverine HCL Injection, USP
 
Phenylephrine HCL Injection, USP
 
Potassium Phosphates Injection, USP
 
Sodium Phosphates Injection, USP 
  
 

 

American Regent can confirm that these products were manufactured in accordance with cGMP and quality requirements and that they meet all USP and other internal monograph and quality release specifications. American Regent is confident in the integrity and quality of these injectable products.

Visit our website at www.americanregent.com for daily updates on product releases and availability or contact our Customer Service Department at: 1-800-645-1706.

We apologize for any inconvenience this temporary suspension of manufacturing and distribution has caused. We appreciate the tremendous support that our customers and partners have given us during this period and for your continued loyalty and confidence in our products.

American Regent will continue to work diligently to research, develop and supply quality injectable products, as it has done since 1967.

If you have any questions or need to place an order for an emergency "drop shipment" please contact our Customer Service Department at 1-800-645-1706 or for more information, please visit our website at: www.americanregent.com
 

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.